Free Trial

Enhabit, Inc. (NYSE:EHAB) Short Interest Update

Enhabit logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest fell 20.6% in February to 1,239,534 shares (about 2.5% of shares outstanding), leaving a very low days-to-cover of roughly 0.3 days based on average daily volume (~4.04M).
  • Analysts hold a consensus "Hold" rating with an average price target of $13.57 (two Buys, six Holds, one Sell); recent activity includes Leerink raising its target to $13.80 and Deutsche Bank upgrading to Buy.
  • Enhabit reported Q4 EPS of $0.14 (in line with estimates) on $270.4M revenue but a slight negative net margin (-0.43%), and EVP Julie Diane Jolley sold 2,793 shares on March 9 — corporate insiders own about 3.40% of the stock.
  • MarketBeat previews top five stocks to own in May.

Enhabit, Inc. (NYSE:EHAB - Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 1,239,534 shares, a drop of 20.6% from the February 12th total of 1,560,640 shares. Currently, 2.5% of the company's shares are sold short. Based on an average daily trading volume, of 4,035,523 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily trading volume, of 4,035,523 shares, the days-to-cover ratio is presently 0.3 days. Currently, 2.5% of the company's shares are sold short.

Insider Buying and Selling at Enhabit

In other news, EVP Julie Diane Jolley sold 2,793 shares of the business's stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $13.63, for a total transaction of $38,068.59. Following the transaction, the executive vice president directly owned 139,923 shares of the company's stock, valued at approximately $1,907,150.49. The trade was a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.40% of the company's stock.

Institutional Investors Weigh In On Enhabit

Hedge funds and other institutional investors have recently bought and sold shares of the business. Osaic Holdings Inc. lifted its holdings in shares of Enhabit by 337.5% during the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company's stock valued at $25,000 after purchasing an additional 2,018 shares during the last quarter. State of Alaska Department of Revenue purchased a new stake in shares of Enhabit in the 3rd quarter worth approximately $27,000. Tower Research Capital LLC TRC grew its stake in shares of Enhabit by 82.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company's stock worth $44,000 after buying an additional 2,059 shares during the last quarter. Russell Investments Group Ltd. increased its position in Enhabit by 523.1% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company's stock valued at $56,000 after buying an additional 4,865 shares in the last quarter. Finally, Simplex Trading LLC raised its stake in Enhabit by 69.8% during the fourth quarter. Simplex Trading LLC now owns 8,115 shares of the company's stock valued at $75,000 after buying an additional 3,336 shares during the last quarter.

Analysts Set New Price Targets

Several analysts recently weighed in on EHAB shares. Leerink Partners lifted their price target on shares of Enhabit from $9.50 to $13.80 and gave the company a "market perform" rating in a report on Monday, February 23rd. Weiss Ratings restated a "sell (e+)" rating on shares of Enhabit in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a "buy" rating in a research report on Tuesday, January 13th. Oppenheimer cut shares of Enhabit from an "outperform" rating to a "market perform" rating in a research report on Monday, February 23rd. Finally, Wolfe Research set a $12.00 price target on shares of Enhabit in a research note on Thursday, January 8th. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Enhabit has a consensus rating of "Hold" and an average price target of $13.57.

Check Out Our Latest Stock Report on Enhabit

Enhabit Stock Up 0.1%

EHAB traded up $0.01 during trading on Friday, reaching $13.61. The stock had a trading volume of 1,384,313 shares, compared to its average volume of 2,706,902. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $690.54 million, a price-to-earnings ratio of -151.27 and a beta of 1.56. The stock's 50 day moving average is $11.57 and its two-hundred day moving average is $9.57. Enhabit has a one year low of $6.47 and a one year high of $13.68.

Enhabit (NYSE:EHAB - Get Free Report) last announced its earnings results on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, meeting analysts' consensus estimates of $0.14. The firm had revenue of $270.40 million for the quarter, compared to analysts' expectations of $270.56 million. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. As a group, analysts expect that Enhabit will post 0.22 earnings per share for the current year.

About Enhabit

(Get Free Report)

Enhabit, Inc NYSE: EHAB is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines